The Bloody Truth Blog
Anemia management in ESRD: On the horns of a dilemma
May 16, 2012
Recently, I have had several queries and personal communications regarding a perceived increase in RBC transfusions for patients with end-stage renal disease (ESRD) on dialysis. The literature is replete with articles surrounding the management of anemia in this patient population, particularly involving the use of erythropoietin-stimulating agents (ESAs). The literature is limited, however, when it comes to clear guidelines for transfusion. In fact, transfusion is most often discouraged in this population if, in particular, the patient is awaiting a transplant where alloimmunization must be avoided.
The Bloody Truth: Ten Facts About Blood Transfusions
Critical Information Every Physician, Nurse, and Hospital Executive Should Know
Upcoming Webinar
Blood Management Communication and Awareness Strategies
Presented by:
Elora Thorpe, RN, MSN
Transfusion Safety Nurse Manager
The University of Kansas Hospital
June 7, 2012, 2 - 3PM ET






